SG10201606161UA - Albumin Formulation and Use - Google Patents

Albumin Formulation and Use

Info

Publication number
SG10201606161UA
SG10201606161UA SG10201606161UA SG10201606161UA SG10201606161UA SG 10201606161U A SG10201606161U A SG 10201606161UA SG 10201606161U A SG10201606161U A SG 10201606161UA SG 10201606161U A SG10201606161U A SG 10201606161UA SG 10201606161U A SG10201606161U A SG 10201606161UA
Authority
SG
Singapore
Prior art keywords
albumin formulation
albumin
formulation
Prior art date
Application number
SG10201606161UA
Other languages
English (en)
Inventor
Sandra Marie Merkel
Luke Dimasi
Collette Ann Sheahan
Phillip Harvey Morton
Original Assignee
Novozymes Biopharma Dk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes Biopharma Dk As filed Critical Novozymes Biopharma Dk As
Publication of SG10201606161UA publication Critical patent/SG10201606161UA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG10201606161UA 2011-07-05 2012-07-05 Albumin Formulation and Use SG10201606161UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161504406P 2011-07-05 2011-07-05
EP11174267 2011-07-15

Publications (1)

Publication Number Publication Date
SG10201606161UA true SG10201606161UA (en) 2016-09-29

Family

ID=47437434

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201606161UA SG10201606161UA (en) 2011-07-05 2012-07-05 Albumin Formulation and Use

Country Status (8)

Country Link
US (1) US10844349B2 (ja)
EP (1) EP2729492B1 (ja)
JP (2) JP6247210B2 (ja)
CN (1) CN103649111B (ja)
BR (1) BR112014000042A2 (ja)
CA (1) CA2838964C (ja)
SG (1) SG10201606161UA (ja)
WO (1) WO2013006675A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105283541B (zh) * 2013-05-30 2019-02-19 味之素株式会社 干细胞培养用培养基
ES2761854T3 (es) 2016-10-04 2020-05-21 Albumedix Ltd Usos de albúmina de suero recombinante obtenida a partir de levadura
JP2020502203A (ja) * 2016-12-21 2020-01-23 プロメティック・ファーマ・エスエムティ・リミテッドＰｒｏｍｅｔｉｃ Ｐｈａｒｍａ Ｓｍｔ Ｌｉｍｉｔｅｄ 上皮間葉転換を予防または最小限にする方法及び組成物
JP7181534B2 (ja) * 2017-03-28 2022-12-01 味の素株式会社 未分化維持培地添加剤
CN112368368B (zh) * 2018-06-15 2024-01-30 扶桑药品工业株式会社 辅助生殖医疗用培养基
JP7240659B2 (ja) * 2018-06-15 2023-03-16 公立大学法人横浜市立大学 精子形成誘導用培地
US20230000774A1 (en) 2019-12-04 2023-01-05 Albumedix Limited Methods and compositions produced thereby
US11767504B2 (en) 2020-08-14 2023-09-26 Albcura Corporation Albumin compositions and methods of producing and using same
EP4442251A1 (en) 2023-04-05 2024-10-09 Albumedix Ltd Formulations and uses thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL66614A (en) 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
EP0465513A1 (en) * 1989-03-27 1992-01-15 Centocor, Inc. FORMULATIONS FOR STABILIZING OF IgM ANTIBODIES
FR2686620B1 (fr) 1992-01-27 1995-06-23 Rhone Poulenc Rorer Sa Serum-albumine humaine, preparation et utilisation.
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5728553A (en) 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
DE4400944A1 (de) * 1994-01-14 1995-07-20 Ursatec Verpackung Gmbh Saug-Druckpumpe für Fluidbehälter
JPH07308199A (ja) 1994-05-18 1995-11-28 Green Cross Corp:The ヒト血清アルブミンの製造方法
EP0889925B1 (en) * 1996-03-27 2004-06-02 Novartis AG Process for manufacture of a porous polymer by use of a porogen
CA2302708A1 (en) 1997-08-21 1999-03-04 Siemens Aktiengesellschaft Method for transmitting user data that can be allocated to different applications
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
US6408210B1 (en) 2000-01-11 2002-06-18 Pacesetter, Inc. System and method for automatic atrial capture detection and atrial pacing threshold determination
CA2405557C (en) 2000-04-12 2013-09-24 Human Genome Sciences, Inc. Albumin fusion proteins
US20080227202A1 (en) * 2000-10-06 2008-09-18 Michael Dancu Method of promoting differentiation of one or more human stem cells into human coronary endothelial cells on a synthetic tubular structure
JP2004536081A (ja) * 2001-06-13 2004-12-02 トーラス エイチエスエイ エルエルシー ヒト血清アルブミンの精製
WO2003059934A2 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin fusion proteins
ES2545090T3 (es) 2001-12-21 2015-09-08 Human Genome Sciences, Inc. Proteínas de fusión de albúmina y GCSF
GB0310347D0 (en) 2003-05-07 2003-06-11 Delta Biotechnology Ltd Assay
WO2005070120A2 (en) 2004-01-09 2005-08-04 Serologicals Investment Company, Inc. Cell culture media
CN1724567B (zh) * 2004-07-22 2010-08-18 北京三元基因工程有限公司 一种稳定的重组人干扰素α1b水溶液
JP2008523829A (ja) 2004-12-22 2008-07-10 ノボザイムス アクティーゼルスカブ 血清アルブミンの組換え生成
CA2634329A1 (en) 2005-12-22 2007-07-19 Csl Behring Gmbh Octanoate-reduced human albumin
WO2008009641A1 (en) 2006-07-17 2008-01-24 Novozymes A/S Cell culture media
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
SG2014012918A (en) 2009-02-11 2014-04-28 Novozymes Biopharma Dk As Albumin variants and conjugates
CN105567699A (zh) 2009-10-30 2016-05-11 诺维信生物制药丹麦公司 白蛋白变体
US20130225496A1 (en) 2010-11-01 2013-08-29 Novozymes Biopharma Dk A/S Albumin Variants

Also Published As

Publication number Publication date
WO2013006675A1 (en) 2013-01-10
EP2729492B1 (en) 2019-01-02
CN103649111B (zh) 2018-03-13
CN103649111A (zh) 2014-03-19
CA2838964C (en) 2021-07-13
JP2017197572A (ja) 2017-11-02
US10844349B2 (en) 2020-11-24
BR112014000042A2 (pt) 2017-02-21
JP2014520535A (ja) 2014-08-25
US20140234966A1 (en) 2014-08-21
JP6247210B2 (ja) 2017-12-13
CA2838964A1 (en) 2013-01-10
EP2729492A1 (en) 2014-05-14

Similar Documents

Publication Publication Date Title
IL236616B (en) 5-aminotetrahydroquinoline-2-carboxylic acids and their use
EP2828258A4 (en) NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE
HK1210714A1 (en) Antibody formulations and uses thereof
HK1201454A1 (en) Therapeutic agents and uses thereof
IL229844B (en) Anti-psgl-1 antibodies and their use
HK1191034A1 (en) N-carboxyalkyl-auristatins and use thereof n-
EP2701730A4 (en) MFG-E8 AND USES THEREOF
SG10201606161UA (en) Albumin Formulation and Use
ZA201501124B (en) Trans-clomiphene formulations and uses thereof
EP2718283A4 (en) INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
IL231082A0 (en) Pyrimido-pyridazinone compounds and their use
PL2521445T3 (pl) Preparat i jego zastosowanie
EP2688588A4 (en) FAST AND LONG-TERM IMMUNOLOGICAL THERAPEUTIC
HK1217688A1 (zh) -氯- 苯基- -茚- -酮及其用途
EP2697386A4 (en) DESIGN AND USE OF PEPDUCINE
AP2014007616A0 (en) Agrochemical formulation and use thereof
EP2693879A4 (en) MIGRASTATINES AND THEIR USES
HK1198587A1 (en) Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals -2-
HK1207154A1 (en) C1q-adiponectin complex and use thereof c1q-
IL229936B (en) Albumin formulation and use
HUE048382T2 (hu) 6-klór-3-(fenil-d5)-inden-1-on és alkalmazása
GB201112578D0 (en) Pharmaceutical preparation and use
GB201113314D0 (en) Formulations and processes
GB201215414D0 (en) Composition and use